ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 148 filers reported holding ANAVEX LIFE SCIENCES CORP in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bank of New York Mellon Corp | 257,700 | $1,687,937 | 0.00% |
LPL Financial LLC | 55,940 | $366,407 | 0.00% |
Cambridge Investment Research Advisors, Inc. | 16,275 | $107 | 0.00% |
CIBC WORLD MARKET INC. | 15,793 | $103 | 0.00% |
Citadel Advisors | 170,200 | $1,114,810 | 0.00% |
Citadel Advisors | 126,800 | $830,540 | 0.00% |
Raymond James Financial Services Advisors, Inc. | 31,155 | $204,065 | 0.00% |
TWO SIGMA ADVISERS, LP | 14,200 | $93,010 | 0.00% |
Daiwa Securities Group Inc. | 314 | $2 | 0.00% |
Steward Partners Investment Advisory, LLC | 650 | $4,258 | 0.00% |
Qube Research & Technologies Ltd | 11,796 | $77,264 | 0.00% |
PEAK6 Investments LLC | 5,000 | $32,750 | 0.00% |
Cresset Asset Management, LLC | 10,450 | $68,448 | 0.00% |
Lindbrook Capital, LLC | 0 | $0 | 0.00% |
External links
This page lists ANAVEX LIFE SCIENCES CORP's shareholders in Q3 2023. To view ANAVEX LIFE SCIENCES CORP's shareholder history, click here.